AS Latvijas Juras medicinas centrs (UOM) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.82x

AS Latvijas Juras medicinas centrs (UOM) has a Cash Flow Reinvestment Rate of 1.82x as of September 2025, reinvesting €861.78K (capex €430.89K plus investments €-430.89K) from operating cash flow of €474.45K. Check AS Latvijas Juras medicinas centrs earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.82x
(Capex + Investments) / Operating CF

Total Reinvested

€861.78K
Capex + Investments

Operating Cash Flow

€474.45K
EUR

Capital Expenditures

€430.89K
EUR

AS Latvijas Juras medicinas centrs Cash Flow Reinvestment Rate (2015–2024)

Historical reinvestment intensity for AS Latvijas Juras medicinas centrs across 10 annual periods. Explore how well can AS Latvijas Juras medicinas centrs service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for AS Latvijas Juras medicinas centrs (2015–2024)

Year-by-year capital reinvestment analysis for AS Latvijas Juras medicinas centrs. For live market cap and broader valuation context, see UOM market cap overview.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 1.44x €872.42K €605.02K €436.21K ▼ -44.4%
2023 2.59x €4.96 Million €1.91 Million €2.48 Million ▲ +92.4%
2022 1.35x €1.47 Million €1.09 Million €629.72K ▼ -74.6%
2021 5.31x €2.22 Million €418.24K €1.11 Million ▲ +277.5%
2020 1.41x €1.03 Million €732.71K €515.12K ▲ +52.9%
2019 0.92x €379.64K €412.86K €190.16K ▲ +112.3%
2018 0.43x €259.66K €599.57K €86.45K ▼ -83.1%
2017 2.57x €1.23 Million €478.41K €605.51K ▼ -35.8%
2016 4.00x €1.67 Million €418.49K €860.13K ▲ +457.5%
2015 0.72x €260.06K €362.36K €260.06K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow